TOKYO, JAPAN - March 29, 2022 - Terumo Corporation (TSE: 4543) today announced that the company commits to achieve carbon neutrality* by 2040 to further mitigate climate change risks. To achieve this goal, Terumo has revised its greenhouse gas (GHG) emission reduction target (Scope 1 and 2) as well as setting a new target to promote the use of renewable energy such as solar power, in addition to conventional energy saving activities. Furthermore, Terumo also advocates GHG emission reductions throughout the value chain such as reducing waste, making effective use of natural resources, developing environmentally friendly products, and advancing joint delivery with other companies.
Based on this revision of the GHG emission reduction target, Terumo has applied to the Science Based Targets initiative (SBTi) for an updated certificate to the "1.5°C target" which is in line with a level to limit the temperature rise to 1.5°C above pre-industrial levels. Terumo received an approval by SBTi in March 2020 for the previous target that commits to pursue global warming prevention efforts of well-below 2°C above pre-industrial levels.
Terumo has also publicly declared its support for the Task Force on Climate-related Financial Disclosures (TCFD) and its recommendations, which was established by the Financial Stability Board (FSB).
Under the Group's corporate mission of "Contributing to Society through Healthcare", Terumo has strived to advance healthcare and enhance patients' quality of life. In addition, Terumo has established the Terumo Group Sustainability Policy in 2021 to solidly realize its Group mission. To reduce the environmental impact of Terumo's business is a part of the sustainability priorities listed in the Policy. By ambitiously committing to achieve carbon neutrality, Terumo Group will work towards shrinking the global issue of climate change.